Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Income from Continuing Operations (2022 - 2024)

Opus Genetics (IRD) has disclosed Income from Continuing Operations for 6 consecutive years, with 40381517.0 as the latest value for Q4 2021.

  • On a quarterly basis, Income from Continuing Operations changed N/A to 40381517.0 in Q4 2021 year-over-year; TTM through Dec 2021 was 56693000.0, a N/A change, with the full-year FY2022 number at 17888000.0, up 131.55% from a year prior.
  • Income from Continuing Operations was 40381517.0 for Q4 2021 at Opus Genetics, down from 1905448.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 40381517.0 in Q4 2021 to a low of 40381517.0 in Q4 2021.